European Innovation Council

Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

FluoGuide A/S is a Copenhagen-based company that focuses on developing surgical solutions to enhance cancer treatment outcomes. Founded in 2018, the company is known for its product FG001, which utilizes a fluorophore that specifically binds to cancer cells expressing the urokinase receptor. By employing intelligent targeting techniques, FluoGuide aims to improve surgical precision, thereby reducing patient suffering and increasing the chances of successful treatment. Additionally, the company seeks to lower healthcare costs associated with cancer surgeries.

Klikkit is a welfare technology platform that focuses on home care, care homes, and hospitals. It specializes in telehealth platforms, health, healthcare, home care, care center, hospitals, digital innovation, digital solutions, technology trends, innovation, and health care management. Klikkit was founded in the year 2018.

Developer of a medical platform intended to deliver clinical decision support for remote care of heart patients with pacemakers. The company's platform leverages machine learning and ethnography to monitor cardiac devices remotely and uses advanced analytics to predict health conditions, enabling chronic patients with digital healthcare that monitors implanted cardiac devices.

Hafnium Labs supports chemicals, energy, and pharma companies by solving one of the biggest challenges in chemistry: Obtaining reliable physical properties fast. From drugs that save our lives, to crop and energy technologies that will save our tomorrow, advances in chemistry change the world. By supporting researchers and engineers working with chemistry we help create a brighter future. We have developed a breakthrough system for combining state-of-the-art predictive methods, such as quantum chemistry and AI, with experimental physical property data. By intelligently and transparently using all available information, we provide the most accurate physical property predictions and quantify the uncertainty, so you know how reliable each prediction is.​ Our Q-props™ tools support decision making from molecular discovery to process optimization. ​Check out our website and reach out to learn more about how to use Q-props™ in your company.